Novartis India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2025 ,inter alia, to consider and approve The Meeting of the Board of ....
NOVARTIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novartis India has informed BSE that its Board of Directors will meet on Tuesday, October 28, 2025 to consider and approve the Unaudited Financial Results along with the Limited Review Report for the quarter and half year ended September 30, 2025. The trading window for designated persons, insiders, and connected persons has been closed from October 1, 2025, and will reopen 48 hours after the results are announced. The intimation is filed under SEBI LODR Regulation 29 and the company's insider trading code.
This is a routine regulatory filing ahead of the Q2 FY26 earnings announcement and does not contain any financial data. The stock may see some pre-result activity, but no fundamental information is disclosed here. Investors should await the October 28, 2025 results for actual performance numbers.